ADVANTAGE OF USING IFN PLUS RIBAVIRIN FOR PATIENTS WITH ELEVATED PRETREATMENT LEVELS OF HCV-RNA

Authors
MORISCO F SESSA G TUCCILLO C DELUCA M CANESTRINI C LANZA AG BLANCO CD FROIO F PIERGROSSI P DASERO C ASCIONE A CAPORASO N
Citation
F. Morisco et al., ADVANTAGE OF USING IFN PLUS RIBAVIRIN FOR PATIENTS WITH ELEVATED PRETREATMENT LEVELS OF HCV-RNA, Hepatology, 28(4), 1998, pp. 2211-2211
Citations number
1
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
Hepatology → ACNP
ISSN journal
02709139
Volume
28
Issue
4
Year of publication
1998
Part
2
Supplement
S
Pages
2211 - 2211
Database
ISI
SICI code
0270-9139(1998)28:4<2211:AOUIPR>2.0.ZU;2-#